Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: Importance of the drug's relative intrinsic efficacy at the mu receptor

Behavioural Pharmacology

Volumn 7, Issue 3, 1996, Pages 261-275

  Morgan, D ^a   Picker, M J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antinociception; Drug discrimination; Individual differences; Morphine; Rat; Sensitivity; Stimulus intensity; Tail withdrawal

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; BUPRENORPHINE; BUTORPHANOL; FENTANYL; LEVALLORPHAN; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALBUPHINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ACTIVITY; DRUG DISCRIMINATION; DRUG SENSITIVITY; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; RECEPTOR INTRINSIC ACTIVITY;

EID: 0029993262     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Aigner TG and Balster RL (1979) Rapid substitution procedure for intravenous drug self-administration studies in rhesus monkeys. Pharmacology Biochemistry and Behavior, 10, 105-112.
2. Ator NA and Griffiths RR (1993) Differential sensitivity to midazolam discriminative-stimulus effects following self-administered versus response-independent midazolam. Psychopharmacology, 110, 1-4.
3. Bisaga and Kostowski (1993) Individual behavioral differences and ethanol consumption in Wistar rats. Physiology and Behavior, 54, 1125-1131.
4. Butelman ER, Winger G, Zernig G and Woods JH (1995) Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 272, 845-853.
5. Colpaert FC and Janssen PAJ (1984) Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization. Journal of Pharmacology and Experimental Therapeutics, 230, 193-199.
6. Colpaert FC, Niemegeers CJE and Janssen PAJ (1976) On the ability of narcotic antagonists to produce the narcotic cue. Journal of Pharmacology and Experimental Therapeutics, 197, 180-187.
7. Deminiere JM, Piazza PV, LeMoal M and Simon H (1989) Experimental approach to individual vulnerability to psychostimulant addiction. Neuroscience and Biobehavioral Reviews, 13, 141-147.
8. Dum JE and Herz A (1981) In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions. British Journal of Pharmacology, 74, 627-633.
9. Dykstra LA (1990) Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. Journal of Pharmacology and Experimental Therapeutics, 254, 245-252.
10. France CP and Woods JH (1990) Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. Journal of Pharmacology and Experimental Therapeutics, 254, 626-632.
11. Harris CM, Emmett-Oglesby MW, Mathis DA and Lal H (1988) Quantal detection and homogeneous sensitivity in a pentylenetetrazol discrimination. Psychopharmacology, 94, 183-187.
12. Harris RA (1980) Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior. Journal of Pharmacology and Experimental Therapeutics, 213, 497-503.
13. Hooks MS, Jones DNC, Holtzman SG, Juncos JL, Kalivas PW and Justice JB Jr (1994) Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole. Psychopharmacology, 116, 217-225.
14. Koek W and Woods JH (1989) Partial generalization in pigeons trained to discriminate morphine from saline. Drug Development Research, 16, 169-181.
15. Lukas SE, Brady JV and Griffiths RR (1986) Comparison of opioid self-injection and disruption of schedule-controlled performance in the baboon. Journal of Pharmacology and Experimental Therapeutics, 238, 924-931.
16. Mathis DA, Emmett-Oglesby MW, Harris CM and Lal H (1987) Quantal nature of generalization and acquisition responding by rats in a drug discrimination task. Psychological Record, 37, 161-165.
17. McMillan DS, Hardwick WC, Cannon DJ and Couch L (1986) Relationship of plasma phencyclidine levels to phencyclidine discrimination in the pigeon. Pharmacology Biochemistry and Behavior, 25, 117-121.
18. Mello NK, Bree MP and Mendelson JH (1981) Buprenorphine self-administration by rhesus monkey. Pharmacology Biochemistry and Behavior, 15, 215-225.
19. Mello NK, Lukas SE, Bree MP and Mendelson JH (1988) Progressive ratio performance maintained by buprenorphine, heroin and methadone in macaque monkeys. Drug and Alcohol Dependence, 21, 81-97.
20. Nishida N, Hasegawa Y, Chiba S, Wakimasu M and Fujino M (1989) Reinforcing effects of the enkephalin analogs, EK-209 and EK-399, in rats. European Journal of Pharmacology, 166, 453-458.
21. O'Callaghan JP and Holtzman SG (1975) Quantification of the analgesic activity of narcotic antagonists by a modified hot- plate procedure. Journal of Pharmacology and Experimental Therapeutics, 192, 497-505.
22. Owens SM, McMillan DE, Hardwick WC and Wessinger WD (1990) Phencyclidine pharmacokinetics and concentration- response relationships in the pigeon. Pharmacology Biochemistry and Behavior, 35, 797-801.
23. Paronis CA and Holtzman SG (1991) Increased analgesic potency of mu agonists after continuous naloxone infusion in rats. Journal of Pharmacology and Experimental Therapeutics, 259, 582-589.
24. Piazza PV, Deminiere JM, LeMoal M and Simon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science, 245, 1511-1513.
25. Picker MJ, Craft RM, Negus SS, Powell KR, Mattox SR, Jones SR, Hargrove BK and Dykstra LA (1992) Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats. Journal of Pharmacology and Experimental Therapeutics, 263, 668-681.
26. Picker MJ, Yarbrough J, Hughes CE, Smith MA, Morgan D and Dykstra LA (1993) Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences. Journal of Pharmacology and Experimental Therapeutics, 266, 756-767.
27. Picker MJ, Smith MA and Morgan D (1994) Assessment of the relative intrinsic efficacy of profadol and meperidine in a pigeon drug discrimination procedure: relevance to partial substitution patterns. Behavioural Pharmacology, 5, 61-70.
28. Pitts RC, West JP, Morgan D, Dykstra LA and Picker MJ (1996) Effects of mu, kappa and mixed-action opioids on positively reinforced behavior: differential antagonism by naltrexone. Behavioural Pharmacology
29. Ronnback L (1990) Morphine preference in individual rats after morphine ingestion. Psychopharmacology, 102, 257-262.
30. Segal DS and Kuczenski R (1987) Individual differences in responsiveness to single and repeated amphetamine administration: Behavioral characteristics and neurochemical correlates. Journal of Pharmacology and Experimental Therapeutics, 242, 917-926.
31. Shannon HE (1983) Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat. Journal of Pharmacology and Experimental Therapeutics, 225, 144-152.
32. Shannon HE and Holtzman SG (1977) Further evaluation of the discriminative effects of morphine in the rat. Journal of Pharmacology and Experimental Therapeutics, 201, 55-66.
33. Smith MA and Picker MJ (1995) Examination of the kappa agonist and antagonist properties of opioids in the rat drug discrimination procedure: influence of training dose and intrinsic efficacy. Behavioural Pharmacology, 6, 703-717.
34. Stolerman IP (1989) Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement. Psychopharmacology, 91, 131-138.
35. Sudakov SK, Konstantinopolsky MA, Surkova LA, Tyurina IV and Borisova EV (1991) Evaluation of Wistar rats' individual sensitivity to the development of physical dependence on morphine. Drug and Alcohol Dependence, 29, 69-75.
36. Tallarida RJ and Murray RB (1987) Manual of Pharmacologie Calculations with Computer Programs. Springer-Verlag, New York, 1987.
37. Walker EA and Young AM (1993) Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. Journal of Pharmacology and Experimental Therapeutics, 267, 322-330.
38. Walker EA, Butelman ER, DeCosta BR and Woods JH (1993) Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. Journal of Pharmacology and Experimental Therapeutics, 267, 280-286.
39. Walker EA, Makhay MM, House JD and Young AM (1994) In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats. Journal of Pharmacology and Experimental Therapeutics, 271, 959-968.
40. Young AM, Masaki MM and Geula G (1992) Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. Journal of Pharmacology and Experimental Therapeutics, 261, 246-257.